Objective: Diabetic auditory neuropathy (DAN) is a common
complication
of diabetes that seriously affects the quality of life in patients.
In this study, we investigate the role of folic acid in the treatment
of DAN in an experimental rat model. Methods: Thirty-two Sprague–Dawley
rats were equally divided into four groups: group 1, normal; group
2, diabetic rats; and groups 3 and 4, diabetic rats treated with folic
acid (40 and 80 mg/kg, respectively). We used some tools to investigate
the therapeutic effect of folic acid on DAN. We evaluated auditory
brain stem response (ABR), estimated the volume and number of spiral
ganglion and the volume of stria vascularis and spiral ligament by
the stereological method, and measured the blood levels of homocysteine
(HCY), malondialdehyde (MDA), and superoxide dismutase (SOD). Results:
Our study showed that folic acid treatment was not significantly effective
in improving structural and functional disorders in DAN, even though
its effectiveness in reducing HCY (P < 0.001)
and MDA (P < 0.05) as oxidative biomarkers was
significant. Conclusion: Folic acid is not effective in relieving
morphological and functional disorders in DAN.